相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mutant p53: a novel target for the treatment of patients with triple-negative breast cancer?
N. C. Synnott et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity
Parker L. Sulkowski et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Non-invasive detection of somatic mutations using nextgeneration sequencing in primary central nervous system lymphoma
Maxime Fontanilles et al.
ONCOTARGET (2017)
Targeting MYC Dependence by Metabolic Inhibitors in Cancer
Himalee S. Sabnis et al.
GENES (2017)
A Retrospective Analysis of Precision Medicine Outcomes in Patients With Advanced Cancer Reveals Improved Progression-Free Survival Without Increased Health Care Costs
Derrick S. Haslem et al.
JOURNAL OF ONCOLOGY PRACTICE (2017)
Molecularly targeted therapies for p53-mutant cancers
Dekuang Zhao et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Optimal alpha reduces error rates in gene expression studies: a meta-analysis approach
J. F. Mudge et al.
BMC BIOINFORMATICS (2017)
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
Gurkan Mollaoglu et al.
CANCER CELL (2017)
Understanding type I and type II errors, statistical power and sample size
Anthony K. Akobeng
ACTA PAEDIATRICA (2016)
Sample size calculation while controlling false discovery rate for differential expression analysis with RNA-sequencing experiments
Ran Bi et al.
BMC BIOINFORMATICS (2016)
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Michele Ceccarelli et al.
CELL (2016)
Pharmacotherapies for the treatment of glioblastoma - current evidence and perspectives
Katharina Seystahl et al.
EXPERT OPINION ON PHARMACOTHERAPY (2016)
Role of tyrosine-kinase inhibitors in myelopro-liferative neoplasms: comparative lessons learned
Javier Pinilla-Ibarz et al.
ONCOTARGETS AND THERAPY (2016)
The genomics and therapeutics of HER2-positive gastric cancer-from trastuzumab and beyond
Ciara M. Kelly et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
Gene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing Analyses
Milena Todorovic Balint et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Contemporary frameless intracranial biopsy techniques: Might variation in safety and efficacy be expected?
Iris S. C. Verploegh et al.
ACTA NEUROCHIRURGICA (2015)
Liquid biopsies in patients with diffuse glioma
Myron G. Best et al.
ACTA NEUROPATHOLOGICA (2015)
Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer
Hideaki Kinugasa et al.
CANCER (2015)
Pharmacological reactivation of p53 as a strategy to treat cancer
J. Zawacka-Pankau et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord
Yuxuan Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Mdm2 and Aurora Kinase A Inhibitors Synergize to Block Melanoma Growth by Driving Apoptosis and Immune Clearance of Tumor Cells
Anna E. Vilgelm et al.
CANCER RESEARCH (2015)
p53 Mutation Directs AURKA Overexpression via miR-25 and FBXW7 in Prostatic Small Cell Neuroendocrine Carcinoma
Zhen Li et al.
MOLECULAR CANCER RESEARCH (2015)
Systems biology of primary CNS lymphoma: from genetic aberrations to modeling in mice
Martina Deckert et al.
ACTA NEUROPATHOLOGICA (2014)
Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck Cancer
Patrick J. Schuler et al.
CLINICAL CANCER RESEARCH (2014)
Liquid Biopsies: Genotyping Circulating Tumor DNA
Luis A. Diaz et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Mutational analysis of primary central nervous system lymphoma
Aurelie Bruno et al.
ONCOTARGET (2014)
Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients
L. Benesova et al.
ANALYTICAL BIOCHEMISTRY (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients
Diego M. Marzese et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2013)
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
Garrett M. Frampton et al.
NATURE BIOTECHNOLOGY (2013)
An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
Dan Rohle et al.
SCIENCE (2013)
Primary CNS lymphoma
Andres J. M. Ferreri et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2012)
Prognostic Value of Free DNA Quantification in Serum and Cerebrospinal Fluid in Glioma Patients
Wei Shi et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2012)
An Integrated Genomic Approach to Identify Predictive Biomarkers of Response to the Aurora Kinase Inhibitor PF-03814735
Kenneth E. Hook et al.
MOLECULAR CANCER THERAPEUTICS (2012)
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
Luis A. Diaz et al.
NATURE (2012)
MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells
Kathleen A. Bridges et al.
CLINICAL CANCER RESEARCH (2011)
Quantitative detection of multiple gene promoter hypermethylation in tumor tissue, serum, and cerebrospinal fluid predicts prognosis of malignant gliomas
Bo-Lin Liu et al.
NEURO-ONCOLOGY (2010)
Detection of mutated BRAFV600E variant in circulating DNA of stage III-IV melanoma patients
Maria Daniotti et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients
Kazuo Koyanagi et al.
CANCER RESEARCH (2006)
Methylated tumor-specific DNA as a plasma biomarker in patients with glioma
KD Weaver et al.
CANCER INVESTIGATION (2006)
Detection and quantification of mutations in the plasma of patients with colorectal tumors
F Diehl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Role of genetic and epigenetic changes in Burkitt lymphoma
MS Lindström et al.
SEMINARS IN CANCER BIOLOGY (2002)
Morphology and diagnosis of primary central nervous system lymphomas
W Feiden et al.
PATHOLOGE (2002)
分享论文
